This fall, drugs from the New England Compounding Center in Framingham, Mass., were linked to more than 700 illnesses and 46 deaths due to meningitis. The company and its sister company Ameridose in Westborough, Mass., closed in October, worsening already existing drug shortages at hospitals in the state.
On Feb. 13, Massachusetts’ Public Health Council approved regulations giving the state health commissioner long-term approval for certain hospitals to receive compounded medications from larger hospitals to ease this shortage, according to the report. These new regulations expand emergency rules approved in November that allowed temporary waivers to restrictions against hospitals sharing medications.
More Articles on the Fungal Meningitis Outbreak:
Hospitals Can Share Drugs to Ease Shortage Under New Massachusetts Regulations
Senate Committee Faults “Bureaucratic Inertia” in Meningitis Outbreak
FDA: Avoid Meningitis Contamination, Discontinue Use of New England Compounding Center Products
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
